Skip to main content
. 2022 Jun 23;61(31):e202201213. doi: 10.1002/anie.202201213

Scheme 5.

Scheme 5

Development of an efficient strategy towards cochlearol B (2) relying on a Catellani reaction and visible‐light‐mediated [2+2] cycloaddition. Comins’ reagent=N‐(5‐chloro‐2‐pyridyl)bis(trifluoromethanesulfonimide), NMMO=N‐methylmorpholine N‐oxide, DMF‐DMA=N,N‐dimethylformaide dimethyl acetal.